Industry Delighted By ‘Fixed’ USMCA
Removes Biologic Exclusivity Requirement And Allows Incentives For Generics
Industry associations in the US and Canada have welcomed revisions to the proposed US-Mexico-Canada trade agreement that remove potentially damaging provisions around biologic data exclusivity and include measures favorable to generics, including incentives for generic competition.
